Transdermal Diagnostics

The world's first 100% needle-free continuous glucose monitor

 

Our Technology

We are pioneering the development of a wearable technology platform to improve the prevention, diagnosis, and management of chronic conditions, starting with diabetes. Our unique sensing architecture, requires no needles and no blood, and instead draws out biological substances through individual hair follicles.

A disposable adhesive skin patch and rechargeable transmitter comfortably sit on the surface of the skin, communicating wirelessly to a dedicated companion app on your smartphone.

 
 
 

Dr Adelina Ilie,

CSO

Dr Luca Lipani,

CEO

Prof Richard Guy,

Advisor

Our Mission

By providing a 100% needle-free and low cost solution, remote health monitoring can be accessible to all.

Our technology equips users with the knowledge to manage and make informed decisions about their health.

 

Changing the Face of Diabetes Management

Our first target is revolutionising diabetes care and management

For People with Type 1 Diabetes - this means providing an affordable and pain-free continuous glucose monitoring approach to avoid acute complications and life threatening hypoglycemic episodes.

For People with Type 2 Diabetes - this means providing accessible glucose control earlier in the disease's life to halt disease progression and development of further complications.

For People with Prediabetes - this is a lifestyle companion to prevent the disease developing in the first place.

Our technology will be the first 100% needle-free, low cost solution, increasing adherance and accessibility of continuous glucose monitoring, giving people control of their blood glucose levels.

 
 

Supported by

Get in Touch

If you're interested in finding out more about our technology, or partnership or investment opportunities, please get in touch below.